The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Epiris announces the sale of Audiotonix

3 Feb 2017 07:00

RNS Number : 9334V
Electra Private Equity PLC
03 February 2017
 

PRESS RELEASE

3 February 2017

 

 

Epiris announces the sale of Audiotonix

 

Epiris is pleased to announce that it has agreed the sale of Audiotonix, a leading manufacturer of audio mixing consoles, to Astorg, a leading European private equity firm. The transaction is anticipated to close in the first quarter of 2017, subject to regulatory approvals.

 

Electra Private Equity PLC ("Electra") is expected to receive proceeds from the sale of £203 million, an uplift of £62 million or 44% and equivalent to an increase in its NAV of 133 pence per share on the valuation of the investment at 30 September 2016. This equates to a return of 4.8x original cost* and an IRR of 51%, assuming completion by the end of March.

 

Audiotonix is the global market leader in the design and manufacture of audio mixing consoles for live events and broadcast sound. Its three premium brands (Allen & Heath, Calrec and DiGiCo) support live sound for a variety of purposes such as concerts, TV broadcasting, theatre shows and major international live events.

 

Epiris initially invested £42 million on Electra's behalf in the acquisition of Allen & Heath in 2013. This was followed by the acquisition of Calrec in March 2014 and a merger with DiGiCo in August of that year to form Audiotonix. Epiris had identified both Calrec and DiGiCo as add-on opportunities prior to investing in Allen & Heath. These three transactions have created a market leader with a strong growth profile.

 

Charles Elkington, Partner at Epiris, said:

 

"This has been a fantastic deal for Epiris and its investors, and clearly demonstrates our strategy in action.

 

"Through structured investment across three valuable brands we have created a global market leader with strong growth prospects. When we made the initial investment we had a clear strategy based on M&A, operational improvement and strategic focus. We have delivered this with two add-on acquisitions, a reorganised supply chain, and successful investment in sales and marketing as well as new product development. As a result the business has more than quadrupled earnings since 2013.

 

"The management team, under James Gordon's passionate and insightful leadership, is exceptional and we wish them all the best for the future."

 

James Gordon, CEO of Audiotonix, said:

 

"Epiris have been an extremely supportive and engaged partner. Their vision and leadership in combining the three businesses and subsequent contribution to the evolution of the group has been invaluable. We now have a solid foundation from which to push into the next stage of our development."

 

Charles Elkington and Ian Wood are responsible for the investment and the exit of Audiotonix. Robert W. Baird advised on the sale with Taylor Wessing providing legal advice.

 

Epiris refers to Epiris Managers LLP acting on behalf of its client Electra Private Equity PLC.

 

Ends 

 

 

 

For further information please contact:

Andrew Honnor, Matthew Goodman, Matthieu Roussellier, Greenbrook Communications +44 (0)20 7952 2000

Nicholas Board and Andrew Kenny, Epiris +44 (0)20 7306 3902

 

 

Note to Editors:

 

About Epiris

Epiris is a top-decile private equity fund manager*.

 

Epiris, together with its predecessor firms, has managed the business and affairs of Electra Private Equity PLC, a listed private equity investment trust, for four decades. Epiris has also managed private equity investment programmes for pension funds, financial institutions and family offices. During this time Epiris has invested in excess of £5 billion in over 200 deals. As at 30 September 2016, the firm had funds under management of

£2.4 billion.

 

Epiris' flexible investment strategy has allowed it to invest broadly across the private equity market, including in buyouts and co-investments, secondaries and debt assets.

 

In respect of buyouts and co-investments and loan-to-own debt investments made since 2011, Epiris has delivered a gross IRR of 37%**.

 

For further information please visit www.epiris.co.uk.

 

Issued by Epiris Managers LLP which is authorised and regulated by the Financial Conduct Authority.

 

* Refers to the 2009 and 2012 investment pools comprising Buyout & Co-investment, Secondary and Debt investments managed on behalf of Electra Private Equity PLC; comparator data supplied by Preqin.

 

** As at 30 September 2016 adjusted for subsequent investments and realisations. Gross IRR does not reflect adjustments for investment management and administration costs. Past performance is no guarantee of future results.

 

About Astorg

Astorg is a European private equity firm with total funds under management of over €4 billion. Astorg seeks to partner with entrepreneurial management teams to acquire European companies and create value through the provision of strategic guidance, experienced governance and adequate capital. Astorg enjoys a distinct entrepreneurial culture, a long-term shareholder perspective, and a lean decision-making body enhancing its reactivity. Though not specialized, Astorg has gathered a valuable industry expertise in healthcare, business-to-business professional services, and technology-based industrial companies. Astorg has offices in London, Paris and Luxembourg, plus Senior Advisors based in Zurich and Frankfurt.

 

For further information about Astorg, please visit www.astorg.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISEAFAAEDKXEAF
Date   Source Headline
11th Jun 20155:14 pmRNSHolding(s) in Company
10th Jun 20156:11 pmRNSDirector/PDMR Shareholding
10th Jun 20152:47 pmRNSAdjustment of Conversion Price of Bonds
4th Jun 20155:18 pmRNSDividend Reinvestment Plan
3rd Jun 20151:05 pmRNSHolding(s) in Company
1st Jun 201510:32 amRNSDirector/PDMR Shareholding
21st May 20157:00 amRNSHalf Yearly Report
20th May 20159:58 amRNSHolding(s) in Company
1st May 201510:56 amRNSTotal Voting Rights
23rd Apr 20154:51 pmRNSHolding(s) in Company
23rd Apr 20159:23 amRNSHolding(s) in Company
20th Apr 20159:42 amRNSHolding(s) in Company
7th Apr 20155:01 pmRNSHolding(s) in Company
1st Apr 201511:53 amRNSTotal Voting Rights
30th Mar 20155:54 pmRNSHolding(s) in Company
30th Mar 20155:50 pmRNSHolding(s) in Company
23rd Mar 201510:15 amRNSHolding(s) in Company
20th Mar 20151:15 pmRNSSpecial Resolution passed at AGM on 16 March 2015
16th Mar 20155:04 pmRNSResult of AGM
16th Mar 201510:01 amRNSHolding(s) in Company
9th Mar 20159:30 amRNSHolding(s) in Company
2nd Mar 201511:53 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSQuarterly Update Report as at 31 December 2014
26th Feb 20157:01 amRNSCircular re Annual General Meeting 16 March 2015
26th Feb 20157:01 amRNSStatement re Announcements by Sherborne
20th Feb 201510:07 amRNSHolding(s) in Company
11th Feb 20157:00 amRNSReview of capital structure, distributions & fees
2nd Feb 201512:06 pmRNSTotal Voting Rights
29th Jan 20155:16 pmRNSHolding(s) in Company
28th Jan 20155:26 pmRNSHolding(s) in Company
26th Jan 20159:40 amRNSHolding(s) in Company
14th Jan 201510:18 amRNSHolding(s) in Company
12th Jan 20155:43 pmRNSHolding(s) in Company
7th Jan 20159:31 amRNSHolding(s) in Company
2nd Jan 201511:27 amRNSTotal Voting Rights
30th Dec 20142:05 pmRNSBlocklisting Interim Review
22nd Dec 201410:02 amRNSHolding(s) in Company
19th Dec 20144:38 pmRNSAnnual Financial Report
8th Dec 20145:26 pmRNSHolding(s) in Company
1st Dec 201412:21 pmRNSTotal Voting Rights
28th Nov 20145:50 pmRNSHolding(s) in Company
27th Nov 201411:42 amRNSHolding(s) in Company
27th Nov 20147:00 amRNSFinal Results
25th Nov 20143:31 pmRNSHolding(s) in Company
19th Nov 20143:17 pmRNSHolding(s) in Company
17th Nov 20144:39 pmRNSHolding(s) in Company
3rd Nov 201412:41 pmRNSTotal Voting Rights
31st Oct 20143:21 pmRNSHolding(s) in Company
30th Oct 20144:25 pmRNSHolding(s) in Company
27th Oct 20143:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.